Centre on Clinical Stroke Research
VASCage
R&D Centre
VASCage is a unique R&D Centre on Clinical Stroke Research.
Science meets industry
We combine the international expertise of top scientists and leading research companies.
Our vision
is to extend the healthy lifespan by prevention and optimal treatment of stroke.
Our strengths
- outstanding clinical and epidemiological expertise
- the alliance with several large hospitals
- broad access to patients
- an own clinical trial platform
Our shareholders
- Medical University of Innsbruck
- University of Innsbruck
OUR FIGHT AGAINST STROKE
- ambitious prevention programs
- improving diagnosis, therapy and rehabilitation
- enabling better coping with the effects of stroke
News & Events
PRESS RELEASE WORLD STROKE DAY 29 OCTOBER
VASCage plans new prevention study among 1,000 healthy Tyrolean adults
Stroke is the second leading cause of death, with more than six million deaths annually worldwide, and the leading cause of permanent disability in adults. One in four people will suffer a stroke at some point in their lives, although most strokes could be prevented. Prevention is therefore the focus of this year's World Stroke Day on 29 October and also one of the most important research areas at the VASCage. So far, the main focus of VASCage prevention research has been on children and adolescents. Now a comprehensive study on a representative group of 1,000 randomly selected Tyrolean adults is also to take place.
VASCage plans new prevention study among 1,000 healthy Tyrolean adults
Stroke is the second leading cause of death, with more than six million deaths annually worldwide, and the leading cause of permanent disability in adults. One in four people will suffer a stroke at some point in their lives, although most strokes could be prevented. Prevention is therefore the focus of this year's World Stroke Day on 29 October and also one of the most important research areas at the VASCage. So far, the main focus of VASCage prevention research has been on children and adolescents. Now a comprehensive study on a representative group of 1,000 randomly selected Tyrolean adults is also to take place.
PRESS RELEASE
The largest study on the smallest lesions - VASCage researcher investigates the epidemiology of small acute brain infarcts on MRI
Stroke is a leading cause of disability in the elderly. Common symptoms of stroke include acute problems with speech or vision, or numbness of an arm or leg, most often caused by a larger brain infarct. In contrast, small acute brain infarcts often are not noticeable - they occur silently and secretly. Yet they may be neither rare nor harmless. On the contrary: research data suggest that these tiny brain infarcts, only a few millimeters in size, are common in old age. Furthermore, individuals with small acute brain infarcts may have an increased risk of a "real" stroke or dementia. However, it is still largely unclear in which groups of people these "mini-infarcts" are most likely to occur and what significance they actually have for health.
The largest study on the smallest lesions - VASCage researcher investigates the epidemiology of small acute brain infarcts on MRI
Stroke is a leading cause of disability in the elderly. Common symptoms of stroke include acute problems with speech or vision, or numbness of an arm or leg, most often caused by a larger brain infarct. In contrast, small acute brain infarcts often are not noticeable - they occur silently and secretly. Yet they may be neither rare nor harmless. On the contrary: research data suggest that these tiny brain infarcts, only a few millimeters in size, are common in old age. Furthermore, individuals with small acute brain infarcts may have an increased risk of a "real" stroke or dementia. However, it is still largely unclear in which groups of people these "mini-infarcts" are most likely to occur and what significance they actually have for health.